MG53 permeates through blood-brain barrier to protect ischemic brain injury

Oncotarget

Volumn 7, Issue 16, 2016, Pages 22474-22485

  Yao, Yonggang ^a   Zhang, Bo ^b,c   Zhu, Hua ^b   Li, Haichang ^b   Han, Yu ^a   Chen, Ken ^a   Wang, Zhen ^a   Zeng, Jing ^a   Liu, Yukai ^a   Wang, Xinquan ^a   Li, Yu ^a   He, Duofen ^a   Lin, Peihui ^b   Zhou, Xinyu ^b   Park, Ki Ho ^b   Bian, Zehua ^b   Chen, Zhishui ^c   Gong, Nianqiao ^c   Tan, Tao ^b   Zhou, Jingsong ^d   Zhang, Meng ^a   Ma, Jianjie ^b   Zeng, Chunyu ^a   more..

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Cell membrane repair; Neuroprotection; Stroke; Tissue plasminogen activator; TRIM72

Indexed keywords

CASPASE 3; RECOMBINANT HUMAN MG53 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MITSUGUMIN 53, HUMAN; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN TISSUE; CELL PROTECTION; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOLOGY; HYPOXIA; IMMUNOBLOTTING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; DRUG EFFECTS; HUMAN; METABOLISM; NERVE CELL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CARRIER PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84965080896     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7965     Document Type: Article

References (42)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015; 131:e29-322.
2. Lee EJ, Chen HY, Hung YC, Chen TY, Lee MY, Yu SC, Chen YH, Chuang IC and Wu TS. Therapeutic window for cinnamophilin following oxygen-glucose deprivation and transient focal cerebral ischemia. Exp Neurol. 2009; 217:74-83.
3. Lee EJ, Chen HY, Lee MY, Chen TY, Hsu YS, Hu YL, Chang GL and Wu TS. Cinnamophilin reduces oxidative damage and protects against transient focal cerebral ischemia in mice. Free Radic Biol Med. 2005; 39:495-510.
4. Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, Komazaki S, Takeshima H and Ma J. MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem. 2009; 284:3314-3322.
5. Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H and Ma J. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin. The Journal of biological chemistry. 2009; 284:15894-15902.
6. Lin P, Zhu H, Cai C, Wang X, Cao C, Xiao R, Pan Z, Weisleder N, Takeshima H and Ma J. Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J. 2012; 26:1875-1883.
7. Zhu H, Lin P, De G, Choi KH, Takeshima H, Weisleder N and Ma J. Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair. J Biol Chem. 2011; 286:12820-12824.
8. Ozato K, Shin DM, Chang TH and Morse HC, 3rd. TRIM family proteins and their emerging roles in innate immunity. Nature reviews Immunology. 2008; 8:849-860.
9. Wang X, Xie W, Zhang Y, Lin P, Han L, Han P, Wang Y, Chen Z, Ji G, Zheng M, Weisleder N, Xiao RP, Takeshima H, Ma J and Cheng H. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair. Circ Res. 2010; 107:76-83.
10. He B, Tang RH, Weisleder N, Xiao B, Yuan Z, Cai C, Zhu H, Lin P, Qiao C, Li J, Mayer C, Ma J and Xiao X. Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in delta-Sarcoglycan-deficient hamsters. Molecular therapy. 2012; 20:727-735.
11. Weisleder N, Takizawa N, Lin P, Wang X, Cao C, Zhang Y, Tan T, Ferrante C, Zhu H, Chen PJ, Yan R, Sterling M, Zhao X, Hwang M, Takeshima M, Cai C, et al. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Science translational medicine. 2012; 4:139ra185.
12. Jia Y, Chen K, Lin P, Lieber G, Nishi M, Yan R, Wang Z, Yao Y, Li Y, Whitson BA, Duann P, Li H, Zhou X, Zhu H, Takeshima H, Hunter JC, et al. Treatment of acute lung injury by targeting MG53-mediated cell membrane repair. Nature communications. 2014; 5:4387.
13. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H and Ma J. MG53 nucleates assembly of cell membrane repair machinery. Nature cell biology. 2009; 11:56-64.
14. Duann P, Li H, Lin P, Tan T, Wang Z, Chen K, Zhou X, Gumpper K, Zhu H, Ludwig T, Mohler PJ, Rovin B, Abraham WT, Zeng C and Ma J. MG53-mediated cell membrane repair protects against acute kidney injury. Science translational medicine. 2015; 7:279ra236.
15. Hwang M, Ko JK, Weisleder N, Takeshima H and Ma J. Redox-dependent oligomerization through a leucine zipper motif is essential for MG53-mediated cell membrane repair. American journal of physiology Cell physiology. 2011; 301:C106-114.
16. Shimada S, Hirabayashi M, Ishige K, Kosuge Y, Kihara T and Ito Y. Activation of dopamine D4 receptors is protective against hypoxia/reoxygenation-induced cell death in HT22 cells. Journal of pharmacological sciences. 2010; 114:217-224.
17. Longa EZ, Weinstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20:84-91.
18. Maghbooli Z and Hossein-Nezhad A. Transcriptome and Molecular Endocrinology Aspects of Epicardial Adipose Tissue in Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Observational Studies. BioMed research international. 2015; 2015:926567.
19. Chen H, Tian M, Jin L, Jia H and Jin Y. PUMA is invovled in ischemia/reperfusion-induced apoptosis of mouse cerebral astrocytes. Neuroscience. 2015; 284:824-832.
20. Gharibani P, Modi J, Menzie J, Alexandrescu A, Ma Z, Tao R, Prentice H and Wu JY. Comparison between single and combined post-treatment with S-Methyl-N, Ndiethylthiolcarbamate sulfoxide and taurine following transient focal cerebral ischemia in rat brain. Neuroscience. 2015; 300:460-473.
21. Liu J, Zhu H, Zheng Y, Xu Z, Li L, Tan T, Park KH, Hou J, Zhang C, Li D, Li R, Liu Z, Weisleder N, Zhu D, Lin P and Ma J. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. Journal of molecular and cellular cardiology. 2015; 80:10-19.
22. Pagliaro P and Penna C. Cardiac postconditioning. Antioxid Redox Signal. 2011; 14:777-779.
23. Hausenloy DJ, Lecour S and Yellon DM. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal. 2011; 14:893-907.
24. Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM and Xiao RP. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res. 2011; 91:108-115.
25. Penna C, Settanni F, Tullio F, Trovato L, Pagliaro P, Alloatti G, Ghigo E and Granata R. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology. 2013; 154:1624-1635.
26. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P and Heusch G. Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways. Circ Res. 2015; 117:279-288.
27. Lacerda L, Somers S, Opie LH and Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovascular research. 2009; 84:201-208.
28. Dziennis S, Jia T, Ronnekleiv OK, Hurn PD and Alkayed NJ. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. The Journal of neuroscience. 2007; 27:7268-7274.
29. Fuster V, Bhatt DL, CaliffRM, Michelson AD, Sabatine MS, Angiolillo DJ, Bates ER, Cohen DJ, Coller BS, Furie B, Hulot JS, Mann KG, Mega JL, Musunuru K, O'Donnell CJ, Price MJ, et al. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. Circulation. 2012; 126:1645-1662.
30. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. The New England journal of medicine. 1995; 333:1581-1587.
31. Schulman D, Latchman DS and Yellon DM. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. American journal of physiology Heart and circulatory physiology. 2002; 283:H1481-1488.
32. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? Journal of molecular and cellular cardiology. 2009; 47:32-40.
33. Ichikawa Y, Miura T, Nakano A, Miki T, Nakamura Y, Tsuchihashi K and Shimamoto K. The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning. Cardiovascular research. 2004; 62:167-175.
34. Labruto F, Yang J, Vaage J and Valen G. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic research in cardiology. 2005; 100:198-207.
35. Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR and Sack MN. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovascular research. 2004; 63:611-616.
36. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X and Ovize M. Postconditioning the human heart. Circulation. 2005; 112:2143-2148.
37. Lois C and Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A. 1993; 90:2074-2077.
38. Weisleder N, Lin P, Zhao X, Orange M, Zhu H and Ma J. Visualization of MG53-mediated cell membrane repair using in vivo and in vitro systems. Journal of visualized experiments. J Vis Exp. 2011; pii: 2717. doi: 10.3791/2717.
39. Li Y, Maher P and Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 1997; 19:453-463.
40. Rupadevi M, Parasuraman S and Raveendran R. Protocol for middle cerebral artery occlusion by an intraluminal suture method. J Pharmacol Pharmacother. 2011; 2:36-39.
41. Lin Y, Zhang JC, Fu J, Chen F, Wang J, Wu ZL and Yuan SY. Hyperforin attenuates brain damage induced by transient middle cerebral artery occlusion (MCAO) in rats via inhibition of TRPC6 channels degradation. J Cereb Blood Flow Metab. 2013; 33:253-262.
42. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP and Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol. 2010; 67:41-52.